Drug Detail

Information about Binimetinib

Generic Name
Binimetinib
IND
MEK162
Brand Name (US)
Manufacturer
Novartis
Drug Type
Delivery
Oral
Approval Status
Phase 3
Indications
Overall Strategy
Oncogenic Signal Path Based
Strategy
Block KIT Signal Path
Drug Category
MEK inhibitor